Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

UCB in the Drug Discovery & Development Pharma 50

UCB

Rank: 35

2021 Rank: 32

Brussels, Belgium
www.ucb.com

2021 Revenues ($USD) : $6,816,860,000
2021 Revenues (foreign currencies) : €5,777,000,000
2021 R&D spend : $1,922,220,000
2021 Number of Employees : 8,561
Fiscal Year End : 12/31/2021
Leader : CEO Jean-Christophe Tellier

Founded nearly a century ago, UCB therapies reached more than 3.7 million patients in 2021. The company enjoyed robust financial growth, with revenue hitting €5.78 billion, increasing 10% in constant exchange rates. In 2021, the Brussels-based company won approval in the EU and Great Britain for Bimzelx (bimekizumab). It launched VIMPAT as an adjunctive therapy for idiopathic generalized epilepsy in Japan and Australia. In 2020, the company acquired Ra Pharma for $2.3 billion. That acquisition gave the company the potential self-injection therapy for myasthenia gravis. In early 2022, the company acquired Zogenix for close to $2 billion. UCB won a new FDA indication for the epilepsy drug fenfluramine, which is now also approved for Lennox-Gastaut syndrome (LGS), a rare type of severe epilepsy. —BB

UCB

[UCB gene therapy facility in Braine l’Alleud, Wallonia, Belgium.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50